Clinical Performance of a Novel 15.5-Day Factory-Calibrated Continuous Glucose Monitoring System in Adults With Diabetes
Authors' conclusion
The novel CGM system was proven to provide accurate and reliable glucose readings in adults with diabetes.
Study context
- Population
- Adults (≥18 years) with diabetes, 3 clinical sites in China120 sensors analysed
- Participants
- 60 adults
- Comparison
- uCGM 100 continuous glucose monitoring (CGM) vs venous plasma reference
- uCGM 100n = 60
- Outcome
- Accuracy vs venous plasma reference
Methodological detailsmulticenter, 3 clinical sites in China
- Multicenter
- 3 clinical sites in China
Performance
As reported in the abstract
Overall mean absolute relative difference (MARD) for the CGM system
7.6%
Overall %20/20 agreement rate for the CGM system
95.5%
%20/20 agreement across wear days and glucose ranges
consistently above 93%
Further findings
%20/20 agreement across wear days and glucose ranges
- %20/20 agreement remained consistently above 93% across wear days and glucose ranges
Usability survey
- Positive feedback
- 99.8%
Safety
- Serious adverse events
- 0
Original publication
Clinical Performance of a Novel 15.5-Day Factory-Calibrated Continuous Glucose Monitoring System in Adults With Diabetes. J Diabetes Sci Technol. Published 18 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →